Hemoglobin E-beta-thalassemia syndrome

MONDO:0016491

Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia.

Also known as: E-beta-thalassemia, HbE-beta-thalassemia syndrome

27 clinical trials for this condition and its sub-types, 5 tagged with Hemoglobin E-beta-thalassemia syndrome itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Beta-thalassemia and related diseases (99)

Including sub-types (27) Tagged with Hemoglobin E-beta-thalassemia syndrome (5)

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New hope for anemia patients: drug may cut need for blood transfusions

Disease control Ongoing

This study tests a drug called luspatercept in people with anemia caused by myelodysplastic syndromes (MDS) or beta-thalassemia who need regular blood transfusions. The goal is to see if the drug is safe and can reduce the number of transfusions needed. About 85 participants in I…

Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Hemoglobin E-beta-thalassemia syndrome

Where it sits in the disease tree

New hope for anemia patients: drug may cut need for blood transfusions